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The 2019 novel coronavirus disease (COVID-19) is a highly contagious zoono-
sis produced by SARS-CoV-2 that is spread human-to-human by respiratory
secretions. It was declared by the WHO as a public health emergency. The
most susceptible populations, needing mechanical ventilation, are the elderly
and people with associated comorbidities. There is an important risk of conta-
gion for anesthetists, dentists, head and neck surgeons, maxillofacial surgeons,
ophthalmologists, and otolaryngologists. Health workers represent between
3.8% and 20% of the infected population; some 15% will develop severe com-
plaints and among them, many will lose their lives. A large number of patients
do not have overt signs and symptoms (fever/respiratory), yet pose a real risk
to surgeons (who should know this fact and must therefore apply respiratory
protective strategies for all patients they encounter). All interventions that have
the potential to aerosolize aerodigestive secretions should be avoided or used
only when mandatory. Health workers who are: pregnant, over 55 to 65 years
of age, with a history of chronic diseases (uncontrolled hypertension, diabetes
mellitus, chronic obstructive pulmonary diseases, and all clinical scenarios
where immunosuppression is feasible, including that induced to treat chronic
inflammatory conditions and organ transplants) should avoid the clinical
attention of a potentially infected patient. Health care facilities should priori-
tize urgent and emergency visits and procedures until the present condition
stabilizes; truly elective care should cease and discussed on a case-by-case basis
for patients with cancer. For those who are working with COVID-19 infected
patients' isolation is compulsory in the following settings: (a) unprotected close
contact with COVID-19 pneumonia patients; (b) onset of fever, cough, short-
ness of breath, and other symptoms (gastrointestinal complaints, anosmia, and
dysgeusia have been reported in a minority of cases). For any care or interven-
tion in the upper aerodigestive tract region, irrespective of the setting and a
confirmed diagnosis (eg, rhinoscopy or flexible laryngoscopy in the outpatient
setting and tracheostomy or rigid endoscopy under anesthesia), it is strongly
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recommended that all health care personnel wear personal protective equip-
ment such as N95, gown, cap, eye protection, and gloves. The procedures
described are essential in trying to maintain safety of health care workers dur-
ing COVID-19 pandemic. In particular, otolaryngologists, head and neck, and
maxillofacial surgeons are per se exposed to the greatest risk of infection while
caring for COVID-19 positive subjects, and their protection should be consid-
ered a priority in the present circumstances.
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1 | THE FACTS
The 2019 novel coronavirus disease (COVID-19) pandemic
started in December 2019 in the city of Wuhan, Hubei
province in China. It is a highly contagious zoonosis (with
a reproductive number of 2.8, which means that under
preexisting conditions one case generates 2.8 new cases)
produced by a beta coronavirus (SARS-CoV-2) that is
spread human-to-human largely by respiratory secretions
and occasionally by feces.1,2 Over a few weeks the disease
spread to other Asian countries, to Europe, to the Ame-
ricas and finally across the world demonstrating a rapid
doubling time (6.4 days) and an asymptomatic but highly
infectious prodrome.2,3 On 20 January 2020, it was
declared by the WHO to represent a public health emer-
gency. According to the Johns Hopkins Dashboard, as of
20 March 2020, 166 countries and 274 180 patients had
been confirmed to be infected, 11 375 have died and
87 991 have recovered. The infections occurred predomi-
nantly (87%) in people of 30 to 79 years old.4 Most infec-
tions (81%) are asymptomatic or produce only mild
symptoms, whereas 15% occur in severe form that has
required hospitalization. Some 3% to 4% benefit from
respiratory support in an intensive care unit (ICU).4 The
death rate has been calculated between 0.39% and 4%, but
this depends upon patient age and is much higher in those
older than 70 years.1,4 The most likely population to
require mechanical ventilation are the elderly and people
with associated comorbidities (in particular cardiovascular
disease and hypertension, followed by diabetes mellitus)
with a predicted mortality of around 15% to 49%.4
Transmission is mainly produced by symptomatic
patients, but it has been reported that even asymptomatic
individuals and those in the incubation period (which can
last longer than 14 days), can also be a source of occult
transmission.4 Swab polymerase chain reaction results for
most asymptomatic patients turn negative in about
3 days, while symptomatic patients typically have detect-
able virus for 12 to 20 days.3,5 There is still little informa-
tion about the transmission during the recovering phase.1
Most patients treated by head and neck surgeons have
cancer, the direct role of SARS-CoV-2 infection in their
outcomes is unknown. To date, there is no clear evidence
that patients with cancer have an increased risk of infec-
tion or severe disease, beyond the immunosuppression
caused by the malignancy itself.6 However, patients with
cancer have experienced a higher risk of death due to the
limitations of access imposed by social distancing and the
shortage of operating rooms (ORs) and ICU beds.7




The first reported physician fatality related to COVID-19
in Wuhan, China was that of an otolaryngology physician
on 25 January 2020.8 In Wuhan epidemic statistics,
health workers represented 3.8% of the infected, 14.8%
had severe disease, and the overall mortality rate was of
0.6%.1,4,9 On the other hand, in Italy, 20% of responding
health care workers were infected, and some have died.10
People in contact with symptomatic patients, such as
health personnel, are the most susceptible to infection.
The most commonly infected health care personnel
worked in general wards.11
Human-to-human spread occurs through respiratory
secretions (although fecal-oral spread has also been con-
firmed) so health care personnel that manage patients
with diseases of the aerodigestive tract (dentists, otolaryn-
gologists, head and neck surgeons, gastroenterologists,
pneumonologists, respiratory therapists, speech thera-
pists, and infectious disease physicians) or ophthalmolo-
gists are the most susceptible health care workers to
become infected (risk ratio of 2.13).1,12,13 Therefore it was
rapidly recognized that there is a particular need for pro-
tective measures in these professional groups.14
In cases of COVID-19 patients with known respira-
tory disease, protective measures are usually followed by
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surgeons. However, a significant number of patients do
not have fever or respiratory symptoms (13%-30%), so
surgeons should apply respiratory protective strategies
for all patients. This is especially true in tropical coun-
tries, where symptoms can simulate other viral infectious
diseases such as dengue.15 The classical symptoms of the
infection are fever, dry cough, and shortness of breath.
The syndrome rarely resembles a classical “cold” or with
a runny nose that helps distinguish it from the common
viral flu. Nonetheless, precautions must be taken for all
patients with flu-like symptoms.
Recent reports from sites around the world have
shown that anosmia and dysgeusia are significant symp-
toms associated with the COVID-19 pandemic. Anosmia,
in particular, has been seen in patients ultimately testing
positive for the coronavirus with no other symptoms. For
this reason, the American Academy of Otolaryngology
(AAO-HNSF) has proposed that these symptoms be added
to the list of screening tools for possible COVID-19 infec-
tion. (https://www.entnet.org/content/aao-hns-anosmia-
hyposmia-and-dysgeusia-symptoms-coronavirus-disease).
All procedures that have the potential to aerosolize
aerodigestive secretions, such as nasolaryngoscopy, endo-
tracheal intubation, noninvasive ventilation, transnasal
endoscopic surgery, and high-speed handpieces or ultra-
sonic instruments, increase the risk of infection and
should be avoided or employed only when mandatory.1,16
There is no information regarding any potential risk for
electrocautery smoke or transoral laser resection generated
smoke but it would be reasonable to take appropriate pre-
cautions in these settings too.
Due to the characteristics of the virus, the standard
protective measures of daily workflow do not prevent the
infection, and specific masks (N-95 or FFP2 or higher) or
powered air-purifying respirator (PAPR), other personal
protective equipment (PPE) and dedicated sterilization
measures should be implemented to avoid the infec-
tion.17,18 However, one case series report that none of
41 health workers that had contact with aerosolized
secretions of COVID-19 positive patients and employed
standard PPE, developed an infection. It suggests that the
rate of infection, when standard measures are employed,
is considerably lower than when they are not used or are
used improperly.12,19 One of the more important reasons
to explaining health care workers infection may be
related to the lack of PPE and education about its correct
use.9 It has been suggested that standard measures prop-
erly followed are more successful than the quick imple-
mentation of complex protection strategies.12,20
Pregnancy, age over 55 years, some chronic diseases
(chronic hepatitis, renal diseases, diabetes mellitus, auto-
immune diseases, and cancer) represent risk factors for
developing severe acute respiratory distress syndrome;
affected health workers should not take care for infected
patients.21 There is no information about intrauterine or
transplacental transmission to the newborn.22,23
The disease also imposes a physical, mental, and emo-
tional burden to health care workers.24 Most physicians
caring for infected patients and for patients considered
“suspicious” for infection become more quickly exhausted.
There is also a specific risk associated with “health anxi-
ety”; a phenomenon defined as “anxiety that occurs when
perceived sensations of changes are interpreted as symp-
toms of being ill.” 25 This occurs commonly in daily life,
but in times of infectious diseases outbreaks, this phenome-
non can produce detrimental effects. Today, (accurate, but
often also incorrect) information about the clinical course,
rate of complications, and mortality of COVID-19 is inces-
santly emphasized and widespread through media and
social networks. This increases the frequency and severity
of health anxiety, characterized by catastrophic misinter-
pretation of sensations, wrong beliefs about the disease's
consequences, and dysfunctional coping.25,26 As more
information is received and more ensues, excess anxiety
results in a loss of the ability to make rational decisions.
Specifically for surgeons, this situation could have two
polar effects: first, some people may see doctors as a source
of contagion and avoid them (and thus, medical assis-
tance); second, other people may see them as source of
security and visit them repeatedly, putting a further burden
on strained health services. Both situations increase the
risk for surgeons: in the first case, they can be threatened
in public areas and in the second their capacity to help
may be overwhelmed. An infection-related xenophobia is
also a potential risk for foreign surgeon's practice.11,27
Finally, the impact of financial concerns of health
care workers on their wellbeing and performance should
not be underestimated.
3 | RECOMMENDATIONS FOR
CLINICAL AND ENDOSCOPIC
EXAMINATION
The risk of contamination is very high in upper respira-
tory examinations. In Chinese patients, SARS-Cov-2 was
detected in 63% of nasopharyngeal swabs, in 46% of the
fiber-optic bronchoscopic brush biopsies and in 93% of
bronchoalveolar lavage fluid specimens.28 Higher viral
loads were detected after symptoms onset of COVID-19,
with higher viral load in the nose than in the throat.29 In
spite of that, recommendations for clinical and endo-
scopic examination can be very controversial because
adequate PPE to all staff involved in patient care cannot
be available everywhere. For sure, at least “WHO infec-
tion prevention and control (IPC) standards” should be
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in place at international level. Disruption of supply
chains and depletion of stock of PPE can drive anxiety in
health professionals.30
The Working Group of 2019 Novel Coronavirus,
Peking Union Medical College Hospital,21 criteria for the
selection of front-line medical personnel included passing
physical examinations and professional training for
COVID-19. Candidates were excluded if they were preg-
nant, aged over 55 years, had history of chronic diseases
such as chronic hepatitis, renal diseases, diabetes
mellitus, autoimmune diseases, and tumors. All individ-
uals with acute fever were also excluded. For those who
are working with COVID-19 suspicious or infected
patients, isolation or observation was compulsory in the
following conditions: (a) those with close unprotected
contact with COVID-19 pneumonia patients (health
workers should be relatively isolated, “avoiding walking
around and extensive contact with others”); (b) onset of
fever, cough, shortness of breath, and other symptoms
(medical personnel should be isolated immediately and
receive appropriate care); (c) when work in the COVID-
19 infection ward is finished, nasopharyngeal, or oropha-
ryngeal swabs for COVID-19 and a full blood count
should be carried out. Those who have abnormal test
results should undergo strict isolation and observation;
while others will be generally isolated for observation
and resume work after 1 week. However, there are no
consensus on these recommendations as to how long
COVID-19-positive health care professionals should
refrain from patient care. Viral secretion was found in
hospitalized Chinese patients who recovered to last from
8 to 37 days with a median of 20 days.5
During the COVID-19 pandemic status, effective bio-
safety precautions must be implemented in all clinics and
hospitals because most infected patients are not symp-
tomatic and may have been examined only with inade-
quate protection. Medical and dental examinations and
procedures can produce aerosols. Even subsequent
patients in the same room or suite are at elevated
risk.1,31,32 Consequently, health care professionals are at
high risk of contamination.
Aiming to preserve and ensure staff and patient
safety, the USA Center for Diseases Control (CDC) rec-
ommends that health care facilities cease elective care
and restrict their activities to providing urgent and emer-
gency visits and procedures for several weeks. All elective
and nontime sensitive, nonurgent surgical procedures
and admissions must be rescheduled as necessary.33 In
other parts of the world, like Hong Kong, and, and most
recently, Italy, France, and Belgium, there has also been
a reduction in elective clinics and operations, with the
aim of prioritizing the use of personnel and available
facilities to the diagnostic and therapeutic pathways of
COVID-19 management. However, most oncologic inter-
ventions are still proceeding in the belief that cancer sur-
gery is time-sensitive. It would be prudent to confirm
that the patient is SARS-CoV-2 free through swab testing.
This recommendation must change when the situation
becomes critical and the whole health care facility is
under strain from COVID-19 patients.8 This may ensue
even in more-developed countries.
Working in the epicenter of the current pandemic,1
169 staff workers involved in a dental emergency unit at
the School and Hospital of Stomatology, Wuhan, China
have treated >700 patients with emergent dental care
since January 24 under using adequate protection mea-
sures. Since February 3, they have also provided consulta-
tions to >1600 patients on an online platform. No
COVID-19 infection has been reported among the staff,
confirming the effectiveness of the established infection
control measures in COVID-19 prevention within dental
settings. They established triage stations to measure and
record the temperature of all staff and patients. Patients
and accompanying persons were provided with medical
masks and temperature measurement once they entered
the hospital. All the dentists undertook strict personal
protection measures and avoided techniques that could
produce aerosols. Rubber dams and high-volume saliva
ejectors were used to minimize aerosol or spatter during
the surgical procedures. Face shields and goggles were
considered essential with use of drilling with water spray.
A four-handed technique and saliva ejectors were consid-
ered beneficial.
4 | RISK REDUCTION USING
REMOTE TRIAGING FOR NEW
REFERRALS AND FOLLOW-UPS
To break the chain of transmission, several health care
jurisdictions are recommending reduced footfall in hospi-
tals. Thus, structured telephone triaging can be used to
separate low-risk from high-risk patients, with the latter
cohort being seen sooner. Using one such risk calculator
generated iteratively from over 10 000 patients in the
United Kingdom, the risk of missing cancer in low-risk
patients who do not undergo a face-to-face consultation
is under 2%.34 Such patients can be reassessed at a later
time when the acute pandemic associated issues are
resolved. This approach has been supported by ENTUK,
the British Association of Otolaryngology-Head and Neck
Surgery.
Similarly, it has been well recognized that the detec-
tion of recurrent cancers is low in the population of
asymptomatic patients after treatment. These patients
need support with functional problems. They should be
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offered remote consultation; only those with new symp-
toms should be offered face-to-face consultation for the
duration of the pandemic.35
5 | INDICATIONS AND CARE
DURING INTUBATION AND
TRACHEOSTOMY
Head and neck surgeons, otolaryngologists, maxillofacial
surgeons, and anesthetists are at high risk of contamina-
tion and infection by SARS-CoV-2 when assisting
patients with tracheostomy or performing a rhinoscopy
or a laryngoscopy because of the generation of aerosols.
Fortunately, tracheostomy is unlikely to be required for
the majority of patients. All patients must be examined
by a physician wearing PPE such as N95 or FFP2 mask
or PAPR, gown, cap, eye protection, and gloves.8,28 For a
tracheostomy, all staff must keep PPE with a PAPR
throughout the procedure.11
The Royal College of Surgeons has posted guidance
for surgical tracheostomy during the COVID-19 pan-
demic (https://www.entuk.org/tracheostomy-guidance-
during-covid-19-pandemic), with advice as to decreasing
the risk of aerosolization: stop ventilation while the tra-
cheostomy window is being performed, and only resume
ventilation when the cuff of the tracheostomy tube has
been inflated.
Zuo et al presented the Chinese Society of Anesthesi-
ology Task Force on Airway Management recommenda-
tions for proper practice of tracheal intubation by
frontline anesthesiologists and critical care physicians in
critically ill patients with COVID-19 disease.36 Intubation
is considered a high-risk procedure due to the physician
exposure to secretions, blood, droplets, and aerosols, and
should be indicated only for patients with severe respira-
tory distress or hypoxemia after standard oxygen therapy.
It should be undertaken in an airborne isolation room
and enhanced droplet/airborne PPE should be applied to
all the health care workers, including N95 masks, hair
cover, protective coverall, gown, gloves, face shields and
goggles (prepared for antifog), and shoe covers. If avail-
able, a protective head hood or PAPR should be used.
Whenever possible, it should be performed by an experi-
enced anesthesiologist with assistance of another physi-
cian. Airway assessment before intervention is regarded
as crucial. All airway management tools must be dispos-
able and available including a videolaryngoscope with
disposable blades, and devices for needle or scalpel
cricothyroidotomy. According to Aminnejad et al37 and
Yang et al,38 the administration of intravenous lidocaine
prior to tracheal extubation can reduce coughing without
side-effects, and it can be recommended also for
intubation aiming to reduce the risk for the physician
who is doing the procedure. Several specific recommen-
dations are also afforded for an anticipated difficult air-
way. The endotracheal tube must be secure and then the
patient is put in mechanical ventilation. All devices must
be collected in double-sealed bags and proper disinfection
implemented during disposal. All equipment and envi-
ronment surfaces must be cleaned and disinfected.36
Akin to the physicians at high risk, allied health and
nursing professionals who care for patients with head
and neck diseases continue to be at high risk. Problem-
atic settings include postoperative tracheostomy care and
valve changes for laryngectomees. These personnel
should adhere to the same PPE recommendations as for
other professional groups involved in airway
interventions.
6 | OPERATING ON PATIENTS
WITH COVID-19
In preparation for the COVID-19 pandemic, Wong et al39
reviewed OR outbreak response measures. Several rec-
ommendations can be implemented worldwide, others
must be adapted according to the resource availability.
An OR with a negative pressure environment is ideal to
reduce dissemination of the virus. A high frequency of
air changes (25 per hour) reduces viral load within the
OR. Separate ORs can be designated for surgery in
patients suspected or confirmed to have COVID-19. Each
OR must have its own ventilation system with an inte-
grated high-efficiency particulate air filter. These ORs
should be separated from the main OR complex to reduce
the risk of contaminating other ORs. Traffic and flow of
contaminated air can be minimized by locking all doors
to the OR during surgery, with only one possible route
for entry and exit. It is considered important to have a
program for the use of PPE. All health care personnel
must be trained in the use of PPE. Postoperative visits
must be suspended and replaced by phone calls to reduce
movement of staff around the hospital.
Ti et al40 recommend that an OR with a negative pres-
sure environment with separate access must be used to
operate suspected or confirmed cases of COVID-19 infec-
tion. They also advocate that the same room and the
same anesthesia machine should be used for all COVID-
19 patients during the epidemic. During the surgical pro-
cedure, a runner wearing PPE is stationed outside the OR
in case other drugs or equipment are needed.
The current recommendations of the American Acad-
emy of Otolaryngology-Head and Neck Surgery is that all
elective surgical treatments should be rescheduled, but it
is unavoidable to provide surgical care to patients with
1264 KOWALSKI ET AL.
time-sensitive, urgent, or emergent medical conditions
(https://www.entnet.org/content/coronavirus-disease-2019-
resources).41 Many of these patients have cancer, are older,
have nutritional problems, comorbid conditions and
some have undergone radiation and chemotherapy with
possible depressed immunity.42 To date, there is insuffi-
cient information on the effect of COVID-19 in patients
with cancer.
No reported series of patients who underwent emer-
gency head and neck surgery exist till date. Hence, one
must extrapolate from the experience in other areas to
develop a strategy for patients with head and neck cancer
requiring emergency surgery. According to Chen et al,43
the National Health Commission of China recommends
collecting nasopharyngeal swab samples to test for
COVID-19 and have a chest computed tomography
(CT) for all pregnant infected patients. Patients must be
transferred between the isolation ward and the OR by a
negative pressure isolation transfer cabin. All the person-
nel involved must wear level 3 protective medical equip-
ment (BSL-3). A negative pressure OR must be used and
its preparation and personal protection include the use of
BSL-3 (N95 masks, goggles, protective suits, disposable
medical caps, and rubber gloves). Medical personnel
should enter and exit the OR in accordance with the prin-
ciples of clean area, contaminated pollution area, and
two buffer zones. Designated nurses must ensure the
implementation of standard procedures.43 For those who
receive general anesthesia, endotracheal intubation and
PAPR are mandatory.44
Chen et al43 used rapid inhalation (2 minutes) induc-
tion of general anesthesia (8% sevoflurane in 100% oxy-
gen) followed by intravenous injections of 2% lidocaine
(1-1.5 mg/kg), remifentanil (1-2 mg/kg), and succinylcho-
line choline (1-2 mg/kg) to ensure optimal intubating
conditions. All the patients included in their study were
parturients and sevoflurane was used to maintain anes-
thesia before delivery, with sufentanil (0.25-0.35 μg/kg)
and an infusion of propofol (50-100 μg kg−1 min−1) used
to maintain anesthesia after delivery.
After the surgical procedure, the anesthesia worksta-
tion was disinfected for 2 hours with an anesthesia circuit
sterilizer (containing 12% hydrogen peroxide). Chlorine-
containing disinfectant (2000 mg/L) was used to clean the
OR floor and wipe the surface of all reusable medical
equipment. All medical devices, such as surgical instru-
ments, were soaked for 30 minutes in 2000 mg/L
chlorine-containing disinfectant, then sealed and col-
lected into double-layer disposable medical waste bags in
the cleaning room and sent to the designated disinfection
area. After the OR was cleaned, the air purification sys-
tem was shut down after 30 minutes of continuous opera-
tion of negative pressure laminar flow. Then, an ultra-low
volume of 3% hydrogen peroxide (20-30 mL/m) was used
to closed fumigate the OR for 2 hours. Finally, the nega-
tive pressure ventilation of the OR was turned on again.
All medical staff who were involved in surgical procedure
were required to have a SARS-CoV-2 virus detection test
(reverse transcription polymerase chain reaction of naso-
pharyngeal swabs) and CT scans once every 2 weeks.43
Surgeons performing endoscopic sinus surgery seem
to be at particular risk due to the high concentration of
viral particles in the nasopharyngeal region. The most
recent Stanford University guidelines advise canceling
elective cases. For COVID-positive patients that cannot
be rescheduled, use PAPRs if at all possible.16
7 | CONCLUSIONS
The world is experiencing an unprecedented challenge
during the COVID-19 pandemic. Lessons learned include
the need to “flatten the curve” and prevent spread in the
community; increased risks of transmission to otolaryngol-
ogists, oral maxillofacial surgeons, dentists, and anesthesi-
ologists; and tactics to limit the risk of spread. Rigorous
adherence to infection control measures and attention to
rapidly changing policies and procedures is essential to
mitigate the spread of this disease. New challenges are
emerging, including the ability provide care for patients
with an urgent need for time-sensitive care, such as
patients with head and neck cancer, when our health care
systems are at running capacity and/or overwhelmed.
This review summarizes some of the more readily
available clinical protocols for head and neck specialists
caring for patients in an environment of a SARS CoV-2
mediated COVID-19 pandemic. Recommendations are
based largely on relatively small series, often from single
centers, and national position statements. Some represent
expert opinion and application from experiences with
other diseases. Resources and policies may vary not only
between countries, but also between hospitals.
The medical community is accruing information rap-
idly and standards are likely to change quickly with addi-
tional results. We must learn from one another as the
disease crosses the globe so as to integrate the lessons
into practice before too many patients and their care-
givers succumb in the pandemic. Only time will reveal
which approaches are most robust and generally applica-
ble. Head and neck specialists should not allow their
commitment to patient care override self-preservation—
health care personnel form the most valuable resource in
every country during the pandemic. There is a need for
system and hospital-based decision making to support
health care teams, which are composed of dedicated but
vulnerable individuals.
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